Key Lab of Biotechnology of Antibiotics, Ministry of Health, Institute of Medicinal Biotechnology, CAMS & PUMC, 100050, Beijing, China.
Curr Microbiol. 2011 Jan;62(1):16-20. doi: 10.1007/s00284-010-9664-8. Epub 2010 May 19.
Bitespiramycin (BT), a multi-component antibiotic consisted mainly of 4"-isovalerylspiramycin I, II and III, is produced by Streptomyces spiramyceticus WSJ-1, a recombinant spiramycin-production strain that harbored the 4"-O-acyltransferase gene (ist) from Streptomyces mycarofaciens 1748, which could isovalerylate the 4"-OH of spiramycin. To eliminate the production of components 4"-isovalerylspiramycin II and III, therefore reducing the component complexity of BT, inactivation of the sspA gene, which encodes the 3-O-acyltransferase responsible for the acylation of spiramycin I to spiramycin II and III, was performed in Streptomyces spiramyceticus WSJ-1, by in-frame partial deletion. The resulting strain, Streptomyces spiramyceticus WSJ-2, is a 4"-isovalerylspiramycin-I-producing strain as expected.
比太霉素(BT)是一种由主要由 4"-异戊酰螺旋霉素 I、II 和 III 组成的多组分抗生素,由含有来自链霉菌 mycarofaciens 1748 的 4"-O-酰基转移酶基因(ist)的螺旋霉素产生重组菌株 Streptomyces spiramyceticus WSJ-1 产生,该基因可以使螺旋霉素的 4"-OH 异戊酰化。为了消除 4"-异戊酰螺旋霉素 II 和 III 的产生,从而降低 BT 的成分复杂性,通过框内部分缺失失活编码负责螺旋霉素 I 酰化为螺旋霉素 II 和 III 的 3-O-酰基转移酶的 sspA 基因,在 Streptomyces spiramyceticus WSJ-1 中进行。所得菌株 Streptomyces spiramyceticus WSJ-2 如预期的那样是一种 4"-异戊酰螺旋霉素-I 产生菌株。